{"entity":{"type":"insider","cik":"0001493023","url":"/insider/0001493023","json_url":"/insider/0001493023.json","name":"Veneman Ann M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2012-02-21","last":"2017-09-05","span_basis":"filed_date"},"name_variants":[{"name":"Veneman Ann M","source":"filing","n_filings":8,"first_seen":"2012-02-21","last_seen":"2017-09-05"}],"transactions":[{"id":4887111,"accession":"0000899866-17-000160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000160","line_url":"/filing/0000899866-17-000160#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":835.0,"shares_display":"835","price_per_share":145.81,"price_display":"145.81","price_state":"stated","total_value":121751.35,"total_display":"121,751.35","total_whole":"121,751","shares_owned_after":5480.0,"shares_owned_after_display":"5,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-05","scope":"insider"},{"id":4734377,"accession":"0000899866-17-000155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000155","line_url":"/filing/0000899866-17-000155#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":137.74,"price_display":"137.74","price_state":"stated","total_value":96418.0,"total_display":"96,418.00","total_whole":"96,418","shares_owned_after":6315.0,"shares_owned_after_display":"6,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":8048850,"accession":"0000899866-15-000211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000211","line_url":"/filing/0000899866-15-000211#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":895.0,"shares_display":"895","price_per_share":187.48,"price_display":"187.48","price_state":"stated","total_value":167794.6,"total_display":"167,794.60","total_whole":"167,795","shares_owned_after":3252.0,"shares_owned_after_display":"3,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-15","scope":"insider"},{"id":6453111,"accession":"0000899866-14-000266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000266","line_url":"/filing/0000899866-14-000266#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1235.0,"shares_display":"1,235","price_per_share":193.03,"price_display":"193.03","price_state":"stated","total_value":238392.05,"total_display":"238,392.05","total_whole":"238,392","shares_owned_after":3447.0,"shares_owned_after_display":"3,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-15","scope":"insider"},{"id":6690645,"accession":"0000899866-14-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000140","line_url":"/filing/0000899866-14-000140#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1236.0,"shares_display":"1,236","price_per_share":170.01,"price_display":"170.01","price_state":"stated","total_value":210132.36,"total_display":"210,132.36","total_whole":"210,132","shares_owned_after":4682.0,"shares_owned_after_display":"4,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-06","scope":"insider"},{"id":5494732,"accession":"0000899866-13-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-13-000092","line_url":"/filing/0000899866-13-000092#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3115.0,"shares_display":"3,115","price_per_share":99.0,"price_display":"99.00","price_state":"stated","total_value":308385.0,"total_display":"308,385.00","total_whole":"308,385","shares_owned_after":5918.0,"shares_owned_after_display":"5,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-29","filed_date":"2013-05-01","scope":"insider"},{"id":3518146,"accession":"0001231977-12-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231977-12-000080","line_url":"/filing/0001231977-12-000080#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4579.0,"shares_display":"4,579","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":435005.0,"total_display":"435,005.00","total_whole":"435,005","shares_owned_after":6562.0,"shares_owned_after_display":"6,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-12","filed_date":"2012-12-14","scope":"insider"},{"id":2427570,"accession":"0001231977-12-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231977-12-000028","line_url":"/filing/0001231977-12-000028#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001493023","owner_name":"Veneman Ann M","owner_display_name":"Veneman Ann M","owner_url":"/insider/0001493023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":81.1,"price_display":"81.10","price_state":"stated","total_value":162200.0,"total_display":"162,200.00","total_whole":"162,200","shares_owned_after":6128.0,"shares_owned_after_display":"6,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-17","filed_date":"2012-02-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Director","n_filings":8,"first_seen":"2012-02-21","last_seen":"2017-09-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001493023","retrieved_at":"2026-08-26T08:18:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}